Oncology Institute Stock Forecast - Naive Prediction
| TOI Stock | USD 0.15 0 2.67% |
The Naive Prediction forecasted value of Oncology Institute on the next trading day is expected to be 0.12 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.70. Oncology Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Oncology Institute's historical fundamentals, such as revenue growth or operating cash flow patterns.
Oncology |
Oncology Institute Cash Forecast
Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the Oncology Institute's financial statements, enabling forecasts of their impact on future stock prices.
Cash | First Reported 2010-12-31 | Previous Quarter 33.5 M | Current Value 37.5 M | Quarterly Volatility 29.7 M |
Oncology Institute Naive Prediction Price Forecast For the 24th of November
Given 90 days horizon, the Naive Prediction forecasted value of Oncology Institute on the next trading day is expected to be 0.12 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0002, and the sum of the absolute errors of 0.70.Please note that although there have been many attempts to predict Oncology Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Oncology Institute's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Oncology Institute Stock Forecast Pattern
| Backtest Oncology Institute | Oncology Institute Price Prediction | Buy or Sell Advice |
Oncology Institute Forecasted Value
In the context of forecasting Oncology Institute's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Oncology Institute's downside and upside margins for the forecasting period are 0 and 7.35, respectively. We have considered Oncology Institute's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Oncology Institute stock data series using in forecasting. Note that when a statistical model is used to represent Oncology Institute stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.7753 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0115 |
| MAPE | Mean absolute percentage error | 0.0444 |
| SAE | Sum of the absolute errors | 0.6992 |
Predictive Modules for Oncology Institute
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oncology Institute. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Oncology Institute
For every potential investor in Oncology, whether a beginner or expert, Oncology Institute's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oncology Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oncology. Basic forecasting techniques help filter out the noise by identifying Oncology Institute's price trends.View Oncology Institute Related Equities
| Risk & Return | Correlation |
Oncology Institute Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Oncology Institute's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Oncology Institute's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Oncology Institute Market Strength Events
Market strength indicators help investors to evaluate how Oncology Institute stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncology Institute shares will generate the highest return on investment. By undertsting and applying Oncology Institute stock market strength indicators, traders can identify Oncology Institute entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 0.15 | |||
| Day Typical Price | 0.15 | |||
| Price Action Indicator | 0.006 | |||
| Period Momentum Indicator | 0.004 | |||
| Relative Strength Index | 25.72 |
Oncology Institute Risk Indicators
The analysis of Oncology Institute's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oncology Institute's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncology stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.66 | |||
| Standard Deviation | 7.14 | |||
| Variance | 51.04 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Oncology Institute offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncology Institute's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncology Institute Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncology Institute Stock:Check out Historical Fundamental Analysis of Oncology Institute to cross-verify your projections. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share 4.873 | Quarterly Revenue Growth 0.229 | Return On Assets (0.19) | Return On Equity (1.26) |
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.